ApotekstjÄNst Sverige Ab signed an agreement to acquire Svensk Dos AB from Oriola Oyj (HLSE:OKDBV) for SEK 110 million on October 13, 2023. In 2022, Oriola Corporation?s net sales and adjusted EBIT were ?1,403.1 million (SEK 16251.23 million) and ?11.9 million (SEK 137.83 million), respectively. The transaction is subject to the approval of the Swedish Competition Authority (Konkurrensverket) and is expected to be completed no later than in the first quarter of 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.905 EUR | +1.12% | -14.62% | -16.82% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 25 | Transcript : Oriola Oyj, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.82% | 181M | |
+14.35% | 69.79B | |
+7.11% | 8.2B | |
-20.55% | 7.96B | |
-5.04% | 7.91B | |
+2.32% | 4.69B | |
+17.12% | 4.32B | |
-1.24% | 3.99B | |
-3.78% | 3.81B | |
+21.42% | 3.62B |
- Stock Market
- Equities
- OKDBV Stock
- News Oriola Oyj
- ApotekstjÄNst Sverige Ab signed an agreement to acquire Svensk Dos AB from Oriola Oyj.